Chat with us, powered by LiveChat
  • Technology
  • Products
  • Services
    • Compound profiling & Screening
      • Get robust compound data in human tissue models through our OrganoServices. With proven pheno­typic assays in the OrganoPlate® platform, we support your drug discovery and development needs.
    • Custom Model & Assay Development
      • We create novel human tissue and disease models in the OrganoPlate® platform. Our experts are looking forward to developing assays according to your specifications.
    • Drug Development Partnerships
      • Expand your drug discovery capacity, shoulder to shoulder with our scientific team. Proprietary human disease biology in the OrganoPlate® platform. Together we make the therapeutics of tomorrow.
    • All Services
      • We offer several services to support your drug discovery and development needs. Find the overview here.
  • Applications
    • Perfused Tubules
      • Layered tissues with perfused tubules in the absence of artificial membranes form the heart of our permeability and transport science. Study cell interactions, permeability, absorption, transport, and transcytosis without physical barriers.

    • Cell-Cell Interactions
      • Co-culture layered & structured tissues without artificial membranes with perfect imaging, to study barrier-free cellular interactions, cell-cell signaling, and migration.

    • 3D Cell Migration
      • Evaluate the effect of chemotactic triggers or cells on the migration of cells through an extracellular matrix.

    • Angiogenesis
      • Membrane-free microvascular formation and growth through an extracellular matrix (ECM).

    • Vascularization
      • The missing link in tissue culture: add perfusable human vasculature to your tissue models, and recreate sophisticated microenvironments with OrganoPlate® Graft.

    • All Applications
      • OrganoPlate® enables you to study relevant 3D tissue biology by incorporating perfused tubules, co-culture, and full control over the tissue microenvironment. Find the overview of applications here.

  • Resources & Support
    • Knowledge Center
      • Visit our Knowledge Center to get up to speed with 3D tissue culture and to learn how OrganoPlate® supports your research needs.

        Read our publications, application notes, watch our webinars, or check out the supporting protocols and brochures. All compiled for you, by our scientists.

    • Publications
      • Get inspired by peer-reviewed publications of our scientists, partners, and customers around the globe.

    • Case Studies
      • Get inspired by research done by our scientists, partners, and customers around the globe.

    • Blogs
      • Giving you some food for thought. Read our blogs to learn more about 3D tissue culture, research backgrounds, developments, and its future outlook.
    • Workshops & Trainings
      • Kickstart your experiments with the most sophisticated 3D tissue culture platform. Find out which training fits your 3D tissue modeling needs best.
    • Technical Support
      • Any support questions about purchasing, products, or 3D tissue culture and analysis? Get in touch with our experts.
    • Request a quote
      • Thinking of using OrganoPlate for your research? Request a quote for the product(s) of your interest.

    • FAQ
      • Frequently asked questions answered by our experts. Find here the answer you're looking for.
  • About Mimetas
  • Start today with 3D tissue modeling>
    Kickstart successfully your first experiments with the OrganoPlate® through our OrganoStart packages.
  • OrganoFlow® >
    Driving precisely-controlled perfusion flow in the OrganoPlate® platform

  • OrganoTEER® >
    Enabling fast, automated, and impedance-based TEER measurements in OrganoPlate®. Assay 40 tissue culture chips with a few clicks, in less than one minute.

  • Start today with 3D tissue modeling>
    Kickstart your experiments with the most sophisticated 3D tissue culture platform. Find out which training fits your 3D tissue modeling needs best.
  • OrganoPlate® is the solution for all in vitro tissue culture applications. Explore the entire OrganoPlate® family and its dedicated instruments here.

  • Thinking of using OrganoPlate for your research? Request a quote for the product(s) of your interest.

  • Get robust compound data in human tissue models through our OrganoServices. With proven pheno­typic assays in the OrganoPlate® platform, we support your drug discovery and development needs.
  • We create novel human tissue and disease models in the OrganoPlate® platform. Our experts are looking forward to developing assays according to your specifications.
  • Expand your drug discovery capacity, shoulder to shoulder with our scientific team. Proprietary human disease biology in the OrganoPlate® platform. Together we make the therapeutics of tomorrow.
  • We offer several services to support your drug discovery and development needs. Find the overview here.
  • Layered tissues with perfused tubules in the absence of artificial membranes form the heart of our permeability and transport science. Study cell interactions, permeability, absorption, transport, and transcytosis without physical barriers.

  • Co-culture layered & structured tissues without artificial membranes with perfect imaging, to study barrier-free cellular interactions, cell-cell signaling, and migration.

  • Evaluate the effect of chemotactic triggers or cells on the migration of cells through an extracellular matrix.

  • Membrane-free microvascular formation and growth through an extracellular matrix (ECM).

  • The missing link in tissue culture: add perfusable human vasculature to your tissue models, and recreate sophisticated microenvironments with OrganoPlate® Graft.

  • OrganoPlate® enables you to study relevant 3D tissue biology by incorporating perfused tubules, co-culture, and full control over the tissue microenvironment. Find the overview of applications here.

  • Visit our Knowledge Center to get up to speed with 3D tissue culture and to learn how OrganoPlate® supports your research needs.

    Read our publications, application notes, watch our webinars, or check out the supporting protocols and brochures. All compiled for you, by our scientists.

  • Get inspired by peer-reviewed publications of our scientists, partners, and customers around the globe.

  • Get inspired by research done by our scientists, partners, and customers around the globe.

  • Giving you some food for thought. Read our blogs to learn more about 3D tissue culture, research backgrounds, developments, and its future outlook.
  • Kickstart your experiments with the most sophisticated 3D tissue culture platform. Find out which training fits your 3D tissue modeling needs best.
  • Any support questions about purchasing, products, or 3D tissue culture and analysis? Get in touch with our experts.
  • Thinking of using OrganoPlate for your research? Request a quote for the product(s) of your interest.

  • Frequently asked questions answered by our experts. Find here the answer you're looking for.
  • Learn about our mission, vision, the history of the company, and find out what we mean with MIMETAS-do.
EN

Enhanced patient-specific intestine-on-a-chip model for disease modeling and drug discovery

Millions of people worldwide experience pain and stress due to intestinalintestine-on-a-chip inflammation, emphasizing the need for the development of diagnostic strategies and therapeutic interventions. However, without suitable research models for studying intestinal functions, progress in research and drug discovery is difficult. The OrganoPlate® was developed to fill this gap and provides a robust, flexible platform that is amenable to drug screening. Recent adaptations1,2 of a previously established intestine-on-a-chip model3 has paved the way for new opportunities in high-throughput drug discovery and research related to intestinal inflammation.

The OrganoPlate is a microfluidic platform that facilitates research across a wide range of physiological processes, including hepatic, renal, and intestinal function. A recent publication, by scientists at MIMETAS and international collaborators at the University of Sheffield describing the Direct On-Chip Differentiation of Intestinal Tubules from Induced Pluripotent Stem Cells (IPSCs) demonstrates improvements on the existing model, and represents significant progress towards a versatile, more complex platform for future drug discovery efforts.

The need for advanced in vitro models

Inflammatory bowel disease (IBD) is a collective term used to describe a range of disorders involving intestinal inflammation and is estimated to affect more than 6.8 million people globally.4,5 The individual burden of IBD can be significant; those affected commonly experience chronic pain and stress, with symptoms ranging from mild to highly debilitating. Despite the clear need for preventative and therapeutic agents, such solutions are lacking – largely because the underlying mechanisms of intestinal inflammation remain poorly understood. In order to facilitate studies designed to explore intestinal inflammation and potential therapies, there is a need for research models that are:

  • Robust and reproducible
  • Amenable to screening
  • Sufficiently complex
  • Flexible
  • Personalized

In recent years, major efforts have been directed towards the development of in vitro models of intestinal physiology: three-dimensional cultures, organoids, and microfluidics. Each of these provides important biologically relevant features, yet they are typically not suited for high-throughput screening. The OrganoPlate platform helps to fill this gap as it allows for the culturing of leak-tight, polarized epithelial gut tubules on a standardized platform that is compatible with high-throughput screening equipment.6 These features make it a valuable tool in drug discovery settings, as key aspects of IBD pathogenesis,e.g. increased cytokine production and the loss of barrier integrity can be recapitulated.6

As a result, the OrganoPlate has been selected by several pharmaceutical companies to support studies into the mechanisms behind IBD, and diarrhea toxicity observed during a Phase 1 clinical trial.6,7 As that model was based on a single cell line, however, MIMETAS saw room for improvement and recognized the need to expand the OrganoPlate’s capacity for mimicking biological complexity.

Towards patient-specific organoid tubules for personalized medicine approaches

There is no “one-size-fits-all” approach to the treatment of IBD, which is unsurprising given the substantial variation in phenotype and disease course that exists across individuals.8 As with many other conditions, a more personalized approach to the diagnosis and treatment of intestinal inflammation could improve clinical outcomes, as decisions could be based on a deeper understanding of an individual’s specific disease mechanisms. Such an approach has been made possible by technological advances, such as those in genomics and proteomics, but its potential is yet to be realized. For personalized medicine to become a reality, in vitro patient-specific models are needed to mimic intestinal diseases.

With this goal in mind, MIMETAS' scientists and collaborators at the University of Sheffield developed a protocol for the directed differentiation of iPSCs into three-dimensional gut-like tubules in the OrganoPlate. An assessment of stem cell and adult intestinal gene expression markers revealed stepwise differentiation through definitive endoderm, hindgut, and intestinal stages, with barrier function and apical-basal polarity established over the course of two weeks. The iPSC-derived tubules were challenged with a cytokine cocktail to determine their susceptibility to inflammatory stimuli. Following exposure to tumor necrosis factor-α, interleukin-1β, and interferon-γ, an increase in gene expression of IL-6, IL-8, and CCL20 was observed in the tubules, indicating a significant inflammatory response.


Completed in only 14 days, the protocol provides an efficient approach for personalized intestinal model development, without the need for an intermediary organoid step. Unlike organoid models, this approach enables straightforward access to both the apical and basal sides of the epithelium – a crucial consideration for drug development applications.

Related resources


References

  1. Gijzen L, Marescotti D, Raineri E, et al. An Intestine-on-a-Chip Model of Plug-and-Play Modularity to Study Inflammatory Processes. SLAS TECHNOLOGY: Translating Life Sciences Innovation. Published online June 24, 2020:247263032092499. doi:10.1177/2472630320924999
  2. Naumovska E, Aalderink G, Wong Valencia C, et al. Direct On-Chip Differentiation of Intestinal Tubules from Induced Pluripotent Stem Cells. International Journal of Molecular Sciences. 2020;21(14):4964. doi:10.3390/ijms21144964
  3. Trietsch SJ, Naumovska E, Kurek D, et al. Membrane-free culture and real-time barrier integrity assessment of perfused intestinal epithelium tubes. Nature Communications. 2017;8(1). doi:10.1038/s41467-017-00259-3
  4. Alatab S, Sepanlou SG, Ikuta K, et al. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet Gastroenterology & Hepatology. 2020;5(1):17-30. doi:10.1016/s2468-1253(19)30333-4
  5. Jairath V, Feagan BG. Global burden of inflammatory bowel disease. The Lancet Gastroenterology & Hepatology. 2020;5(1):2-3. doi:10.1016/s2468-1253(19)30358-9
  6. Beaurivage C, Naumovska E, Chang Y, et al. Development of a Gut-on-a-Chip Model for High Throughput Disease Modeling and Drug Discovery. International Journal of Molecular Sciences. 2019;20(22):5661. doi:10.3390/ijms20225661
  7. Moisan A, Michielin F, Jacob W, et al. Mechanistic Investigations of Diarrhea Toxicity Induced by Anti-HER2/3 Combination Therapy. Molecular Cancer Therapeutics. 2018;17(7):1464-1474. doi:10.1158/1535-7163.mct-17-1268
  8. Ashton JJ, Mossotto E, Ennis S, Beattie RM. Personalising medicine in inflammatory bowel disease—current and future perspectives. Translational Pediatrics. 2019;8(1):56-69. doi:10.21037/tp.20112.03


Learn more

You might also be interested in:


Visit our Knowledge Center

Cookies

‘May we use cookies?
Hi there! Thanks for visiting our website. We use cookies to keep track of our website statistics to optimize the user experience. We also use cookies for marketing purposes. You can set your preferences by selecting the options below.

Accept all
Accept selected
Decline all